Phase
Condition
Cardiac Disease
Chest Pain
Arrhythmia
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient meets accepted AHA/ACC/HRS guideline indications for catheter ablation ofparoxysmal or persistent AF
First or subsequent ablation procedures may be included
Age 18-75
Exclusion
Exclusion Criteria:
Known venous malformations or implanted instrumentation (IVC filter)
Known PV stenosis
Unable to provide consent
H/O mechanical mitral valve replacement (unable to rely on EA mapping only)
Documented left atrial thrombus
Prior ASD repair Pregnancy
NYHA >=3
EF less than 35%
CHF within 90 daysRecent MI or coronary revascularization within 90 days
NOTE: H/O implanted pacemaker or ICD with transvenous leads will NOT be an exclusioncriteria, but we will track patients treated with pre-existing transvenous leads withthe hypothesis that although fluoroscopy use will be higher in these patients comparedto those without leads, but still lower than conventionally treated patients.
Patients who are undergoing non- standard of care ablations ie, Cyro or FIRM ablations
Study Design
Study Description
Connect with a study center
Beacon Medical Group
South Bend, Indiana 46601
United StatesSite Not Available
Brigham's Women's Hospital
Boston, Massachusetts 02115
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.